Eyes
Alpha-2 agonist eye drops
Alpha-2 agonist eye drop for glaucoma
Other names: brimonidine, Alphagan P, apraclonidine, Iopidine
FAA guidance
Acceptable in the FAA document cited.
Examiner
CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam
The FAA's glaucoma medication sheet lists apraclonidine (Iopidine) and brimonidine (Alphagan P) as CACI glaucoma medication, as a single agent or in a combination product.
Track your medicationsCompare FAA documents: Alpha-2 agonist eye dropsWhat each of the two FAA documents says, in plain wordsOpen
The FAA's CACI – Glaucoma Worksheet lists alpha agonist (Alphagan) among its acceptable medications.
The FAA's CACI – Glaucoma Worksheet says the examiner can issue if the pilot meets all of its acceptable certification criteria, which include the examiner's review of a current, detailed clinical progress note from a clinic visit with the treating physician or specialist no more than 90 days before the exam.
Show the FAA's words: Alpha-2 agonist eye dropsThe official FAA wording: two passages, each with its document and dateOpen
CACI Glaucoma Medications (as a single agent or in a combination product)
Alpha2 Agonist: apraclonidine (Iopidine), brimonidine (Alphagan P)
To determine the applicant’s eligibility for certification, the AME must review a current, detailed Clinical Progress Note generated from a clinic visit with the treating physician or specialist no more than 90 days prior to the AME exam
If the applicant meets ALL the acceptable certification criteria listed below, the AME can issue
Medications [ ] None or Prostaglandin analogs (Xalatan, Lumigan, Travatan or Travatan Z), Carbonic anhydrase inhibitor (Trusopt and Azopt), Beta blockers (Timoptic, etc), or Alpha agonist (Alphagan). Combination eye drops are acceptable